1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro ADME-Tox Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global In Vitro ADME-Tox Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Vitro ADME-Tox Market Perspective (2017-2028)
2.2 In Vitro ADME-Tox Growth Trends by Region
2.2.1 In Vitro ADME-Tox Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In Vitro ADME-Tox Historic Market Size by Region (2017-2022)
2.2.3 In Vitro ADME-Tox Forecasted Market Size by Region (2023-2028)
2.3 In Vitro ADME-Tox Market Dynamics
2.3.1 In Vitro ADME-Tox Industry Trends
2.3.2 In Vitro ADME-Tox Market Drivers
2.3.3 In Vitro ADME-Tox Market Challenges
2.3.4 In Vitro ADME-Tox Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro ADME-Tox Players by Revenue
3.1.1 Global Top In Vitro ADME-Tox Players by Revenue (2017-2022)
3.1.2 Global In Vitro ADME-Tox Revenue Market Share by Players (2017-2022)
3.2 Global In Vitro ADME-Tox Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro ADME-Tox Revenue
3.4 Global In Vitro ADME-Tox Market Concentration Ratio
3.4.1 Global In Vitro ADME-Tox Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro ADME-Tox Revenue in 2021
3.5 In Vitro ADME-Tox Key Players Head office and Area Served
3.6 Key Players In Vitro ADME-Tox Product Solution and Service
3.7 Date of Enter into In Vitro ADME-Tox Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro ADME-Tox Breakdown Data by Type
4.1 Global In Vitro ADME-Tox Historic Market Size by Type (2017-2022)
4.2 Global In Vitro ADME-Tox Forecasted Market Size by Type (2023-2028)
5 In Vitro ADME-Tox Breakdown Data by Application
5.1 Global In Vitro ADME-Tox Historic Market Size by Application (2017-2022)
5.2 Global In Vitro ADME-Tox Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Vitro ADME-Tox Market Size (2017-2028)
6.2 North America In Vitro ADME-Tox Market Size by Type
6.2.1 North America In Vitro ADME-Tox Market Size by Type (2017-2022)
6.2.2 North America In Vitro ADME-Tox Market Size by Type (2023-2028)
6.2.3 North America In Vitro ADME-Tox Market Share by Type (2017-2028)
6.3 North America In Vitro ADME-Tox Market Size by Application
6.3.1 North America In Vitro ADME-Tox Market Size by Application (2017-2022)
6.3.2 North America In Vitro ADME-Tox Market Size by Application (2023-2028)
6.3.3 North America In Vitro ADME-Tox Market Share by Application (2017-2028)
6.4 North America In Vitro ADME-Tox Market Size by Country
6.4.1 North America In Vitro ADME-Tox Market Size by Country (2017-2022)
6.4.2 North America In Vitro ADME-Tox Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In Vitro ADME-Tox Market Size (2017-2028)
7.2 Europe In Vitro ADME-Tox Market Size by Type
7.2.1 Europe In Vitro ADME-Tox Market Size by Type (2017-2022)
7.2.2 Europe In Vitro ADME-Tox Market Size by Type (2023-2028)
7.2.3 Europe In Vitro ADME-Tox Market Share by Type (2017-2028)
7.3 Europe In Vitro ADME-Tox Market Size by Application
7.3.1 Europe In Vitro ADME-Tox Market Size by Application (2017-2022)
7.3.2 Europe In Vitro ADME-Tox Market Size by Application (2023-2028)
7.3.3 Europe In Vitro ADME-Tox Market Share by Application (2017-2028)
7.4 Europe In Vitro ADME-Tox Market Size by Country
7.4.1 Europe In Vitro ADME-Tox Market Size by Country (2017-2022)
7.4.2 Europe In Vitro ADME-Tox Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro ADME-Tox Market Size (2017-2028)
8.2 Asia-Pacific In Vitro ADME-Tox Market Size by Type
8.2.1 Asia-Pacific In Vitro ADME-Tox Market Size by Type (2017-2022)
8.2.2 Asia-Pacific In Vitro ADME-Tox Market Size by Type (2023-2028)
8.2.3 Asia-Pacific In Vitro ADME-Tox Market Share by Type (2017-2028)
8.3 Asia-Pacific In Vitro ADME-Tox Market Size by Application
8.3.1 Asia-Pacific In Vitro ADME-Tox Market Size by Application (2017-2022)
8.3.2 Asia-Pacific In Vitro ADME-Tox Market Size by Application (2023-2028)
8.3.3 Asia-Pacific In Vitro ADME-Tox Market Share by Application (2017-2028)
8.4 Asia-Pacific In Vitro ADME-Tox Market Size by Region
8.4.1 Asia-Pacific In Vitro ADME-Tox Market Size by Region (2017-2022)
8.4.2 Asia-Pacific In Vitro ADME-Tox Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In Vitro ADME-Tox Market Size (2017-2028)
9.2 Latin America In Vitro ADME-Tox Market Size by Type
9.2.1 Latin America In Vitro ADME-Tox Market Size by Type (2017-2022)
9.2.2 Latin America In Vitro ADME-Tox Market Size by Type (2023-2028)
9.2.3 Latin America In Vitro ADME-Tox Market Share by Type (2017-2028)
9.3 Latin America In Vitro ADME-Tox Market Size by Application
9.3.1 Latin America In Vitro ADME-Tox Market Size by Application (2017-2022)
9.3.2 Latin America In Vitro ADME-Tox Market Size by Application (2023-2028)
9.3.3 Latin America In Vitro ADME-Tox Market Share by Application (2017-2028)
9.4 Latin America In Vitro ADME-Tox Market Size by Country
9.4.1 Latin America In Vitro ADME-Tox Market Size by Country (2017-2022)
9.4.2 Latin America In Vitro ADME-Tox Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro ADME-Tox Market Size (2017-2028)
10.2 Middle East & Africa In Vitro ADME-Tox Market Size by Type
10.2.1 Middle East & Africa In Vitro ADME-Tox Market Size by Type (2017-2022)
10.2.2 Middle East & Africa In Vitro ADME-Tox Market Size by Type (2023-2028)
10.2.3 Middle East & Africa In Vitro ADME-Tox Market Share by Type (2017-2028)
10.3 Middle East & Africa In Vitro ADME-Tox Market Size by Application
10.3.1 Middle East & Africa In Vitro ADME-Tox Market Size by Application (2017-2022)
10.3.2 Middle East & Africa In Vitro ADME-Tox Market Size by Application (2023-2028)
10.3.3 Middle East & Africa In Vitro ADME-Tox Market Share by Application (2017-2028)
10.4 Middle East & Africa In Vitro ADME-Tox Market Size by Country
10.4.1 Middle East & Africa In Vitro ADME-Tox Market Size by Country (2017-2022)
10.4.2 Middle East & Africa In Vitro ADME-Tox Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vitro ADME-Tox Introduction
11.1.4 Charles River Revenue in In Vitro ADME-Tox Business (2017-2022)
11.1.5 Charles River Recent Developments
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In Vitro ADME-Tox Introduction
11.2.4 Labcorp Revenue in In Vitro ADME-Tox Business (2017-2022)
11.2.5 Labcorp Recent Developments
11.3 Envigo
11.3.1 Envigo Company Details
11.3.2 Envigo Business Overview
11.3.3 Envigo In Vitro ADME-Tox Introduction
11.3.4 Envigo Revenue in In Vitro ADME-Tox Business (2017-2022)
11.3.5 Envigo Recent Developments
11.4 Curia
11.4.1 Curia Company Details
11.4.2 Curia Business Overview
11.4.3 Curia In Vitro ADME-Tox Introduction
11.4.4 Curia Revenue in In Vitro ADME-Tox Business (2017-2022)
11.4.5 Curia Recent Developments
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec In Vitro ADME-Tox Introduction
11.5.4 Evotec Revenue in In Vitro ADME-Tox Business (2017-2022)
11.5.5 Evotec Recent Developments
11.6 Bioduro-Sundia
11.6.1 Bioduro-Sundia Company Details
11.6.2 Bioduro-Sundia Business Overview
11.6.3 Bioduro-Sundia In Vitro ADME-Tox Introduction
11.6.4 Bioduro-Sundia Revenue in In Vitro ADME-Tox Business (2017-2022)
11.6.5 Bioduro-Sundia Recent Developments
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza In Vitro ADME-Tox Introduction
11.7.4 Lonza Revenue in In Vitro ADME-Tox Business (2017-2022)
11.7.5 Lonza Recent Developments
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec In Vitro ADME-Tox Introduction
11.8.4 WuXi AppTec Revenue in In Vitro ADME-Tox Business (2017-2022)
11.8.5 WuXi AppTec Recent Developments
11.9 IQVIA
11.9.1 IQVIA Company Details
11.9.2 IQVIA Business Overview
11.9.3 IQVIA In Vitro ADME-Tox Introduction
11.9.4 IQVIA Revenue in In Vitro ADME-Tox Business (2017-2022)
11.9.5 IQVIA Recent Developments
11.10 Tecan Group
11.10.1 Tecan Group Company Details
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group In Vitro ADME-Tox Introduction
11.10.4 Tecan Group Revenue in In Vitro ADME-Tox Business (2017-2022)
11.10.5 Tecan Group Recent Developments
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron In Vitro ADME-Tox Introduction
11.11.4 Pharmaron Revenue in In Vitro ADME-Tox Business (2017-2022)
11.11.5 Pharmaron Recent Developments
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Details
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon In Vitro ADME-Tox Introduction
11.12.4 Shanghai Medicilon Revenue in In Vitro ADME-Tox Business (2017-2022)
11.12.5 Shanghai Medicilon Recent Developments
11.13 ChemPartner
11.13.1 ChemPartner Company Details
11.13.2 ChemPartner Business Overview
11.13.3 ChemPartner In Vitro ADME-Tox Introduction
11.13.4 ChemPartner Revenue in In Vitro ADME-Tox Business (2017-2022)
11.13.5 ChemPartner Recent Developments
11.14 Joinn Laboratories
11.14.1 Joinn Laboratories Company Details
11.14.2 Joinn Laboratories Business Overview
11.14.3 Joinn Laboratories In Vitro ADME-Tox Introduction
11.14.4 Joinn Laboratories Revenue in In Vitro ADME-Tox Business (2017-2022)
11.14.5 Joinn Laboratories Recent Developments
11.15 RTI International
11.15.1 RTI International Company Details
11.15.2 RTI International Business Overview
11.15.3 RTI International In Vitro ADME-Tox Introduction
11.15.4 RTI International Revenue in In Vitro ADME-Tox Business (2017-2022)
11.15.5 RTI International Recent Developments
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Details
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific In Vitro ADME-Tox Introduction
11.16.4 Eurofins Scientific Revenue in In Vitro ADME-Tox Business (2017-2022)
11.16.5 Eurofins Scientific Recent Developments
11.17 Aragen Life Sciences
11.17.1 Aragen Life Sciences Company Details
11.17.2 Aragen Life Sciences Business Overview
11.17.3 Aragen Life Sciences In Vitro ADME-Tox Introduction
11.17.4 Aragen Life Sciences Revenue in In Vitro ADME-Tox Business (2017-2022)
11.17.5 Aragen Life Sciences Recent Developments
11.18 Sai Life Sciences
11.18.1 Sai Life Sciences Company Details
11.18.2 Sai Life Sciences Business Overview
11.18.3 Sai Life Sciences In Vitro ADME-Tox Introduction
11.18.4 Sai Life Sciences Revenue in In Vitro ADME-Tox Business (2017-2022)
11.18.5 Sai Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
